I'M MADELEINE LU

Iterion Therapeutics -- Iterion Pharmaceuticals is a venture-backed, clinical stage biotechnology company developing novel targeted cancer therapeutics.

Goose Capital -- Goose Capital is an investment firm comprised of former Fortune 500 executives, industry leaders, and serial entrepreneurs. We invest in breakthrough technologies and innovative founders. Goose Capital invests around $10 million per year, and currently has over 20 companies in its portfolio, financing multiple early stage companies every year. I lead deal diligence on healthcare/med tech deal flow.

Business Angel Minority Association (baMa) -- At baMa I engage with business angels committed to investing and supporting early-stage (pre-seed – series A) startups led by minority founders or early-stage startups that are focused on minority-issues. I maintain and organize the membership database. I also perform initial diligence and pitch evaluation on startups in the baMa pipeline. Additionally, I create marketing material to bring in new dealflow.

Fannin Innovation Studiosm Houston TX -- Fannin Innovation Studio is an early-stage life sciences development group focused on commercializing innovation developed in the Texas Medical Center institutions. Led by an experienced team of managers with diverse business backgrounds, commercialization experience, and strong entrepreneurial knowhow, Fannin partners with promising life science innovators to co-found and actively manage startup companies.

Graduate Research Assistant, Department of Biomedical Engineering at the University of Houston -- I engineer lab-on-a-chip devices for sickle cell disease characterization in patients treated with novel therapies. Additionally, I also optimize cellular therapies in leukemia through sized-based cell separation using microfluidic technologies

Undergraduate Research at the University of Texas Health Science Center - San Antonio, TX -- My role was to extract macrophages from peritoneal, liver, and kidney samples for primary cell culture. Furthermore, I elucidated mechanisms of macrophage chemotaxis and gene expression under various stimuli.

Undergraduate Researcher at the University of Michigan - Ann Arbor, MI -- In their Department of Biophysics and under the direction of Dr. Yang, I developed the fluorescent reporter protein (securin-mCherry) for the tracking of single cell development in embryonic models and cell-free extracts using droplet-based microfluidics.

Undergraduate Researcher at the University of Texas San Antonio. -- I aided in designing in vitro 3D micro-scaffolding of co-culture bacterial systems for high-throughput antimicrobial screening.

Visiting Fellow at the Stanford Research Institute - Menlo Park, CA. -- Under the guidance of Dr. Tom Shaler I performed mass spectrometry on Alzheimer’s Disease proteins to detect racemization and autolysis at asparagine residues in Tau(244-274) protein fragment.

 Department of Biomedical Engineering in the Sergey Shevkoplyas Blood Microfluidics Lab --  Organizations: American Women in Science; Society of Women Engineers

 STEM Scholars Program funded by the National Science Foundation --  MARC U*STAR Fellowship funded by the National Institute of General Medicine --  Honors Program